Given that CIN and associated cGAS/STING activation are enhanced in tumors lacking defined resistance mechanisms, it may be hypothesized that CIN is associated with EGFR-TKI resistance, independent of specific genomic alterations. The gene discussed is CGAS; the disease is cervical squamous intraepithelial neoplasia.